MyMD Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Revenue Information - Schedule of Revenue by Product Lines (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Total product Revenues	$ 420,812	$ 557,089	$ 1,497,448	$ 1,386,165
MicroParticle Catalyzed Biosensor ("MPC") [Member]
Total product Revenues	13,595	(18,798)	102,259	106,832
Particle ImmunoFiltration Assay ("PIFA") [Member]
Total product Revenues	398,650	567,262	1,279,625	1,183,327
Rapid Enzymatic Assay ("REA") [Member]
Total product Revenues			85,000	55,000
Other [Member]
Total product Revenues	$ 8,567	$ 8,625	$ 30,564	$ 41,006